{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:59:22Z","timestamp":1772837962017,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008141","name":"Inge and J\u00f8rgen Larsens Memorial Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007438","name":"Hede Nielsen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010347","name":"Manufacturer Einar Willumsens Memorial Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021817","name":"Knud and Edith Eriksen Memorial Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015459","name":"Danish Cancer Society Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejso.2025.110378","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:35:38Z","timestamp":1754980538000},"page":"110378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of hyperthermia on abdominal tissue concentrations of cisplatin during and after intraperitoneal chemotherapy \u2013 insights from a porcine model"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-9557","authenticated-orcid":false,"given":"Christina","family":"Harlev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7215-8323","authenticated-orcid":false,"given":"Mats","family":"Bue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-5197","authenticated-orcid":false,"given":"Elisabeth Krogsgaard","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1688-954X","authenticated-orcid":false,"given":"Mads Kristian Duborg","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6334-3164","authenticated-orcid":false,"given":"Andrea Ren\u00e9","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-4076","authenticated-orcid":false,"given":"Bo Martin","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Vibeke","family":"Schmedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1424-6170","authenticated-orcid":false,"given":"Lone Kjeld","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-2075","authenticated-orcid":false,"given":"Maiken","family":"Stilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejso.2025.110378_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092230","article-title":"Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ejso.2025.110378_bib2","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s00261-021-03081-0","article-title":"Current update on malignant epithelial ovarian tumors","volume":"46","author":"Elsherif","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"10.1016\/j.ejso.2025.110378_bib3","first-page":"280","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2025.110378_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2017.10.030","article-title":"No improvement in long-term survival for epithelial ovarian cancer patients: a population-based study between 1989 and 2014 in the Netherlands","volume":"88","author":"Timmermans","year":"2018","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2025.110378_bib5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial","volume":"24","author":"Aronson","year":"2023","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110378_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","article-title":"Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","volume":"157","author":"Lim","year":"2022","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.ejso.2025.110378_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamasurg.2023.3944","article-title":"Hyperthermic intraperitoneal chemotherapy after interval cytoreductive surgery for patients with advanced-stage ovarian cancer who had received neoadjuvant chemotherapy","volume":"158","author":"Lee","year":"2023","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.ejso.2025.110378_bib8","first-page":"377","article-title":"Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis","volume":"104","author":"Detroz","year":"2004","journal-title":"Acta Chir Belg"},{"issue":"3","key":"10.1016\/j.ejso.2025.110378_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1055-3207(03)00029-2","article-title":"Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents","volume":"12","author":"Sticca","year":"2003","journal-title":"Surg Oncol Clin"},{"issue":"6","key":"10.1016\/j.ejso.2025.110378_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.ejso.2025.110378_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"de Bree","year":"2017","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"10.1016\/j.ejso.2025.110378_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.ejso.2025.110378_bib13","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1245\/s10434-013-3053-z","article-title":"Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality","volume":"20","author":"Votanopoulos","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110378_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1245\/s10434-019-07495-5","article-title":"Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with increased postoperative complications","volume":"27","author":"Hendrix","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110378_bib15","first-page":"207","article-title":"Non-invasive cardiac monitoring by aortic blood flow determination in patients undergoing hyperthermic intraperitoneal intraoperative chemotherapy","volume":"72","author":"Cafiero","year":"2006","journal-title":"Minerva Anestesiol"},{"issue":"27","key":"10.1016\/j.ejso.2025.110378_bib16","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2025.110378_bib17","article-title":"Dynamic assessment of local abdominal tissue concentrations of cisplatin during a HIPEC procedure \u2013 insights from a porcine model","author":"C. B. Harlev","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110378_bib18","article-title":"Overview of microdialysis","author":"Shippenberg","year":"2001","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.ejso.2025.110378_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124040","article-title":"Analysis of free cisplatin in microdialysates and plasma ultrafiltrate by liquid chromatography-tandem mass spectrometry","volume":"1235","author":"Schmedes","year":"2024","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"issue":"6","key":"10.1016\/j.ejso.2025.110378_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110378_bib21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1208\/s12248-017-0108-2","article-title":"Microdialysis as an important technique in systems Pharmacology-a historical and methodological review","volume":"19","author":"Hammarlund-Udenaes","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.ejso.2025.110378_bib22","article-title":"Further investigations in surface area with special reference to its significance in energy metabolism","volume":"115","author":"Brody","year":"1928","journal-title":"Mo Agr Exp Sta Bull"},{"issue":"9","key":"10.1016\/j.ejso.2025.110378_bib23","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of Cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.ejso.2025.110378_bib24","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3389\/fphys.2018.01898","article-title":"Cisplatin-membrane interactions and their influence on platinum complexes activity and toxicity","volume":"9","author":"Martinho","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.ejso.2025.110378_bib25","article-title":"Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics","volume":"17","author":"Jain","year":"2017","journal-title":"Expet Rev Anticancer Ther"},{"issue":"4\u20135","key":"10.1016\/j.ejso.2025.110378_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/bip.10091","article-title":"Density functional theory and surface enhanced raman spectroscopy characterization of novel platinum drugs","volume":"67","author":"Giese","year":"2002","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejso.2025.110378_bib27","doi-asserted-by":"crossref","first-page":"viii6","DOI":"10.1093\/annonc\/mdy268.020","article-title":"21P - cisplatin in NIPEC or HIPEC?","volume":"29","author":"Alvovsky","year":"2018","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110378_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081775","article-title":"The temperature-dependent effectiveness of platinum-based drugs Mitomycin-C and 5-FU during hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer cell lines","volume":"9","author":"Helderman","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ejso.2025.110378_bib29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3748\/wjg.v24.i10.1072","article-title":"Narrow line between benefit and harm: additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells","volume":"24","author":"Cesna","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110378_bib30","first-page":"5011","article-title":"Response of OVCAR-3 cells to cisplatin and hyperthermia: does hyperthermia really matter?","volume":"37","author":"Sukovas","year":"2017","journal-title":"Anticancer Res"},{"issue":"17","key":"10.1016\/j.ejso.2025.110378_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174136","article-title":"New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ejso.2025.110378_bib32","first-page":"878","article-title":"Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to Chemotherapy1","volume":"8","author":"Tannock","year":"2002","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:18:12Z","timestamp":1772806692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325008066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0748798325008066"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110378","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hyperthermia on abdominal tissue concentrations of cisplatin during and after intraperitoneal chemotherapy \u2013 insights from a porcine model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110378"}}